Searched for
MANKIND PHARMA Q4 EARNINGS UPDATE
Mankind Pharma partners Denovo Sciences for AI-led drug discoveryMankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to si...- Explained: Why Tata Elxsi shares crashed 7% after KPIT Tech’s Q1 revenue, profit guidance warningTata Elxsi shares fell sharply on Wednesday after rival KPIT Technologies warned of weaker-than-expected Q1FY27 revenue and margins due to ...
- KPIT Tech shares hit by downgrades, target price cuts. What JPMorgan and other brokerages saidKPIT Technologies shares plunged after the company issued a weak preliminary Q1 FY27 business update, prompting several brokerages, includi...
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- Rahul Jain sees challenging FY27 for KPIT despite strong deal pipelineKPIT Technologies faces near-term growth concerns due to project setbacks, impacting its FY27 outlook. Analysts anticipate a challenging Q1...
- Why KPIT Tech shares crashed 17% today: The BMW & Volkswagen connection explainedKPIT Technologies witnessed a significant 17% stock plunge following a revenue slowdown warning for Q1FY27, primarily due to unexpected cut...
- KPIT Tech shares crash 17% as company expects Q1 revenue decline, sharp hit to marginsKPIT Technologies shares plunged 17% after the company warned of a revenue drop in Q1 FY27, citing unexpected actions from European automak...
- Nike Q4 FY2026: Earnings surprise, China woes and the path aheadNike reported stronger-than-expected quarterly revenue and earnings, supported by improving demand in North America and a recovery in its w...
- NRI Talk| Equities at 45%, gold at 10-12%: Shiv Gupta of Sanctum Wealth's ideal India portfolio for NRIsDespite recent flat equity returns and rupee depreciation, India's long-term growth story remains robust, according to Sanctum Wealth's Shi...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities declined for a second session as investors stayed cautious despite easing geopolitical tensions. Sensex lost nearly 250 poi...
- Oyo IPO: How real is Oyo parent PRISM’s Rs 748 crore net profitOyo IPO: PRISM, formerly Oravel Stays, has reported a Rs 748 crore profit for the nine months ending December 31, 2025, a significant turna...
- Saksoft shares rally 50% in one week. Here's what technical charts indicateSaksoft shares experienced a significant surge, climbing over 14% on Tuesday and an impressive 50% in a single week. This rally follows a d...
- Motilal Oswal's top 4 banking picks ahead of Q1 earnings season. Do you own any?Motilal Oswal has identified its top banking picks ahead of the Q1 earnings season, anticipating strong MSME credit demand. HDFC Bank and I...
- NRI Talk | Rupee depreciation shouldn't deter NRIs; India still offers attractive dollar returns: Feroze AzeezNRIs are questioning India's investment appeal due to recent flat returns and rupee depreciation. However, experts emphasize India's strong...
- Market wrap: Sensex falls 372 points, Nifty closes below 23,950; Kotak Mahindra Bank drops 3%Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...
- Financial changes from July 1, 2026: Check 6 key updates on ITR deadlines, Aadhaar, passport fees, SBI and HDFC Bank credit cardsGet ready for significant financial shifts starting July 1, 2026. Taxpayers face new ITR filing deadlines, while Aadhaar card holders can u...
- Will Sensex, Nifty extend gains or turn volatile? Q1 updates, F&O expiry among 8 factors set to steer stock market this weekIndian markets head into a crucial week with investors tracking Q1 business updates, June F&O expiry, auto sales data, FII flows, crude oil...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
Load More
